182 related articles for article (PubMed ID: 5384462)
21. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
[No Abstract] [Full Text] [Related]
22. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
Mihich E; Mulhern AI
Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
[No Abstract] [Full Text] [Related]
23. Substances with antineoplastic activity. XCVI. Some pharmacological properties and therapeutic synergism of 6-purinyl-N-(2-chloroethyl)thiocarbamate with cytosine arabinoside.
Mĕlka M; Krepelka J; Miko M; Pokorná S; Kejhová I; Reichlová R; Beitová M; Grimová J; Kargerová A; Sedivá J
Neoplasma; 1989; 36(4):419-25. PubMed ID: 2671756
[TBL] [Abstract][Full Text] [Related]
24. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
[No Abstract] [Full Text] [Related]
25. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and two related compounds on a spectrum of tumors.
Sugiura K
Cancer Res; 1967 Mar; 27(3 Pt 2):179-89. PubMed ID: 5227349
[No Abstract] [Full Text] [Related]
26. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
Bhuyan BK; Fraser TJ; Day KJ
Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
[TBL] [Abstract][Full Text] [Related]
27. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).
Shackney SE
Cancer Chemother Rep; 1970 Dec; 54(6):399-429. PubMed ID: 5527022
[No Abstract] [Full Text] [Related]
28. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug.
Bonmassar E; Bonmassar A; Vadlamudi S; Goldin A
Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1089-95. PubMed ID: 5273445
[TBL] [Abstract][Full Text] [Related]
29. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
Shapiro WR; Ausman JI; Rall DP
Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
[No Abstract] [Full Text] [Related]
30. Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
Rosenoff SH; Bostick F; Young RC
Biochem Pharmacol; 1974 Nov; 23(22):3097-106. PubMed ID: 4441409
[No Abstract] [Full Text] [Related]
31. [The organotropy of alkylating activity of dimethylnitrosamine (DMNA) and nitrosomethyl urea (NMH) in vivo].
Krüger FW; Osswald H; Walker G; Schelten E
Z Krebsforsch; 1970; 74(4):434-47. PubMed ID: 4253315
[No Abstract] [Full Text] [Related]
32. [Antitumor activity of various derivatives of nitrosourea].
Ostrovskaia LA; Krugliak SA; Vermel' EM
Vopr Onkol; 1966; 12(10):83-7. PubMed ID: 4301436
[No Abstract] [Full Text] [Related]
33. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
[No Abstract] [Full Text] [Related]
34. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
Saslaw LD; Grindey GB; Kline I; Waravdekar VS
Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
[No Abstract] [Full Text] [Related]
35. Some effects of 1, 3-bis(2-chloroethyl)-1-nitrosourea upon the synthesis of protein and nucleic acids in vivo and in vitro.
Wheeler GP; Bowdon BJ
Cancer Res; 1965 Nov; 25(10):1770-8. PubMed ID: 5859203
[No Abstract] [Full Text] [Related]
36. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
Thomson JM; Maruyama Y; Schwartz S; Hahn E
Radiology; 1971 Oct; 101(1):187-94. PubMed ID: 4329540
[No Abstract] [Full Text] [Related]
37. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
[No Abstract] [Full Text] [Related]
38. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
Ahmann DL; Hahn RG; Bisel HF
Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
[No Abstract] [Full Text] [Related]
39. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
Avery TL; Roberts D
Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
[No Abstract] [Full Text] [Related]
40. [The mechanism of the antitumor effect of nitrosopropylurea (NPU)].
Gorbacheva LB; Kukushkina GV; Sokolova IS
Vopr Onkol; 1969; 15(11):54-60. PubMed ID: 5368840
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
